Avinger Stock News

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Varying stocks: Avinger, Inc. (NASDAQ:AVGR -4.23%), Blonder Tongue Laboratories, Inc. (AMEX:BDR -4.93%) appeared first on Stocks Equity .

Avinger, Inc. (NASDAQ:AVGR) saw a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 1,050,000 shares, an increase of 85.6% from the October 31st total of 565,800 shares. Based on an average daily trading volume, of 1,630,000 shares, the days-to-cover ratio is currently 0.6 days. []

Avinger, Inc. (AVGR) with the stream of -1.98% also noticed, India China SXT Pharmaceuticals, Inc. (SXTC) encountered a rapid change of 3.41% in the last hour of Mondays trading session. The post Blustering Stock: Avinger, Inc. (NASDAQ:AVGR), China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) appeared first on Stocks Equity .

Avinger, Inc. (AVGR) with the stream of -3.85% also noticed, India Avalon GloboCare Corp. (AVCO) encountered a rapid change of -5.23% in the last hour of trading session. Avinger, Inc. The post Traders should follow this: Avinger, Inc. (NASDAQ:AVGR), Avalon GloboCare Corp. (NASDAQ:AVCO) appeared first on Stocks Equity .

In the last trading session, 2.37 million shares of the Avinger Inc. (NASDAQ:AVGR) were traded, and its beta was 1.63. Most recently the companys share price was $0.69, and it changed around -$0.04 or -6.05% from the last close, which brings the market valuation of the company to $69.06M. AVGR currently trades at a discount Avinger Inc. (NASDAQ: AVGR) Stock: Does It Have More Upside? Read More »

Zacks Investment Research cut shares of Avinger (NASDAQ:AVGR) from a hold rating to a sell rating in a report released on Thursday, Zacks.com reports. According to Zacks, Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The companys product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, []

Avinger, Inc. (NASDAQ:AVGR) saw a significant drop in short interest in the month of October. As of October 29th, there was short interest totalling 565,800 shares, a drop of 34.6% from the October 14th total of 865,500 shares. Approximately 0.6% of the companys shares are sold short. Based on an average daily volume of 962,400 []

Vanguard Group Inc. lifted its stake in Avinger, Inc. (NASDAQ:AVGR) by 22.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,556,540 shares of the medical device companys stock after acquiring an additional 820,377 shares during the period. Vanguard Group Inc. []

Avinger (NASDAQ:AVGR) had its target price lowered by Aegis from $2.50 to $2.00 in a research report sent to investors on Monday, Price Targets.com reports. Aegis currently has a buy rating on the medical device companys stock. A number of other research analysts have also commented on the company. B. Riley reissued a buy rating []

FinancialBuzz.coms latest The Buzz Show: Featuring Our Corporate News Recap on Avinger, Inc. receives FDA clearance of the Pantheris system Avinger, Inc. (NASDAQ: AVGR) surged over 36% in premarket trading after the company received FDA clearance of the Pantheris system. The receipt of the FDA clearance for a new clinical indication for the Pantheris image-guided The post The Buzz Show: Avinger, Inc. (NASDAQ: AVGR) Receives FDA Clearance of the Pantheris System first appeared on Financial Buzz .

Today''s hot penny stocks are catching the eyes of investors and we''re diving into everything investors need to know about them on Wednesday!

Avinger Inc. (NASDAQ:AVGR) price closed lower on Tuesday, November 16, dropping -3.72% below its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy

Avinger Inc (NASDAQ:AVGR) received 510(k) clearance from the FDA for a new clinical indication for the Pantheris image-guided atherectomy system. The clearance allows the Company to directly market

(PR-inside.com) New indication expands addressable market for Pantheris REDWOOD CITY, CA / ACCESSWIRE / November 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for a new clinical indication for the Pantheris image-guided atherectomy system. This clearance allows the company to directly market Pantheris for the treatment of in-stent restenosis (ISR) in the lower extremity arteries. "We are excited to receive FDA clearance for the ISR indication, ..

Today's hot penny stocks are catching the eyes of investors and we're diving into everything investors need to know about them on Wednesday! The post Today's Hot Penny Stocks: What's Moving ZSAN, AVGR